RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000069.xml
PDF herunterladen
Semin Liver Dis 2006; 26(4): 348-362
DOI: 10.1055/s-2006-951603
DOI: 10.1055/s-2006-951603
Measurement of Portal Pressure and Its Role in the Management of Chronic Liver Disease
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
18. Oktober 2006 (online)
ABSTRACT
Portal hypertension is a major cause of morbidity and mortality in liver cirrhosis. This article provides a background on the most important aspects of the evaluation of portal hypertension in patients with chronic liver diseases, with special attention to the measurement of portal pressure by hepatic vein catheterization. The rationale, technique, applications, costs, and limitations of measurements of the hepatic venous pressure gradient are thoroughly reviewed. Emerging, noninvasive methodologies for the evaluation of the patient with portal hypertension are also discussed.
KEYWORDS
Portal hypertension - liver cirrhosis - esophageal varices - portal pressure - hepatic venous pressure gradient
REFERENCES
- 1 Viallet A, Marleau D, Huet M et al.. Hemodynamic evaluation of patients with intrahepatic portal hypertension: relationship between bleeding varices and the portohepatic gradient. Gastroenterology. 1975; 69 1297-1300
- 2 Rigau J, Bosch J, Bordas J M et al.. Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. Gastroenterology. 1989; 96 873-880
- 3 Casado M, Bosch J, Garcia-Pagan J C et al.. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology. 1998; 114 1296-1303
- 4 Myers J D, Taylor W J. An estimation of portal venous pressure by occlusive catheterization of an hepatic venule. J Clin Invest. 1951; 30 662
- 5 Burroughs A K, Groszmann R, Bosch J et al.. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?. Gut. 2002; 50 425-427
- 6 Debernardi-Venon W, Bandi J C, Garcia-Pagan J C et al.. CO(2) wedged hepatic venography in the evaluation of portal hypertension. Gut. 2000; 46 856-860
- 7 Viallet A, Joly J G, Marleau D, Lavoie P. Comparison of free portal venous pressure and wedged hepatic venous pressure in patients with cirrhosis of the liver. Gastroenterology. 1970; 59 372-375
- 8 Boyer T D, Triger D R, Horisawa M, Redeker A G, Reynolds T B. Direct transhepatic measurement of portal vein pressure using a thin needle: comparison with wedged hepatic vein pressure. Gastroenterology. 1977; 72 584-589
- 9 Groszmann R J, Bosch J, Grace N D et al.. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage [see comments]. Gastroenterology. 1990; 99 1401-1407
- 10 Steinlauf A F, Garcia-Tsao G, Zakko M F, Dickey K, Gupta T, Groszmann R J. Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements. Hepatology. 1999; 29 1070-1073
- 11 Garcia-Tsao G, Groszmann R J, Fisher R L, Conn H O, Atterbury C E, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985; 5 419-424
- 12 Vorobioff J, Groszmann R J, Picabea E et al.. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology. 1996; 111 701-709
- 13 Moitinho E, Escorsell A, Bandi J C et al.. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999; 117 626-631
- 14 Feu F, Garcia-Pagan J C, Bosch J et al.. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet. 1995; 346 1056-1059
- 15 Reynolds T B, Geller H M, Kuzma O T, Redeker A G. Spontaneous decrease in portal pressure with clinical improvement in cirrhosis. N Engl J Med. 1960; 263 734-739
- 16 Bruix J, Castells A, Bosch J et al.. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996; 111 1018-1022
- 17 Groszmann R J. The hepatic venous pressure gradient: has the time arrived for its application in clinical practice?. Hepatology. 1996; 24 739-741
- 18 Groszmann R J, Glickman M, Blei A T, Storer E, Conn H O. Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology. 1979; 76 253-258
- 19 Lo G H, Lai K H, Cheng J S, Chen M H, Chiang H T. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology. 2001; 33 1060-1064
- 20 Bernard B, Grange J D, Khac E N, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999; 29 1655-1661
- 21 Bosch J, Garcia-Pagan J C. Complications of cirrhosis: I. Portal hypertension. J Hepatol. 2000; 32 141-156
- 22 Graupera M, Garcia-Pagan J C, Pares M et al.. Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers. J Hepatol. 2003; 39 515-521
- 23 de Franchis R, Primignani M. Endoscopic treatments for portal hypertension. Semin Liver Dis. 1999; 19 439-455
- 24 Lo G H, Lai K H, Cheng J S et al.. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology. 2000; 32 461-465
- 25 Gupta T K, Toruner M, Chung M K, Groszmann R J. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology. 1998; 28 926-931
- 26 Spina G P, Arcidiacono R, Bosch J et al.. Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992. J Hepatol. 1994; 21 461-467
- 27 Wanless I R, Wong F, Blendis L M, Greig P, Heathcote E J, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology. 1995; 21 1238-1247
- 28 Garcia-Pagan J C, Villanueva C, Vila M C et al.. Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers. Gastroenterology. 2001; 121 908-914
- 29 Escorsell A, Ruiz D A, Planas R et al.. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology. 2000; 32 471-476
- 30 Moitinho E, Planas R, Bañares R et al.. Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding. J Hepatol. 2001; 35 712-718
- 31 Abecasis R, Kravetz D, Fassio E et al.. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: a preliminary study. Hepatology. 2003; 37 359-365
- 32 D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 1999; 19 475-505
- 33 Grace N D, Groszmann R J, Garcia-Tsao G et al.. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology. 1998; 28 868-880
- 34 NIEC . Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices [see comments]. N Engl J Med. 1988; 319 983-989
- 35 Escorsell A, Bordas J M, Castaneda B et al.. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension. Hepatology. 2000; 31 1061-1067
- 36 Garcia-Pagan J C, Feu F, Bosch J, Rodes J. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: a randomized controlled study. Ann Intern Med. 1991; 114 869-873
- 37 Abraczinskas D R, Ookubo R, Grace N D et al.. Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment?. Hepatology. 2001; 34 1096-1102
- 38 Perez-Ayuso R M, Pique J M, Bosch J et al.. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet. 1991; 337 1431-1434
- 39 Wiest R, Groszmann R J. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology. 2002; 35 478-491
- 40 de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000; 33 846-852
- 41 D'Amico G, de Franchis R. Upper digestive bleeding in cirrhosis: post-therapeutic outcome and prognostic indicators. Hepatology. 2003; 38 599-612
- 42 Pomier-Layrargues G, Kusielewicz D, Willems B et al.. Presinusoidal portal hypertension in non-alcoholic cirrhosis. Hepatology. 1985; 5 415-418
- 43 Wongcharatrawee S, Groszmann R J. Diagnosing portal hypertension. Baillieres Best Pract Res Clin Gastroenterol. 2000; 14 881-894
- 44 Perello A, Escorsell A, Bru C et al.. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology. 1999; 30 1393-1397
- 45 Navasa M, Bosch J, Mastai R et al.. Measurement of hepatic blood flow, hepatic extraction and intrinsic clearance of indocyanine green in cirrhosis: comparison of a non-invasive pharmacokinetic method with measurements using hepatic vein catheterization. Eur J Gastroenterol Hepatol. 1991; 3 305-312
- 46 Groszmann R J. The measurement of liver blood flow using clearance techniques. Hepatology. 1983; 3 1039-1040
- 47 Zeeh J, Lange H, Bosch J et al.. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology. 1988; 95 749-759
- 48 Groszmann R J, Atterbury C E. The pathophysiology of portal hypertension: a basis for classification. Semin Liver Dis. 1982; 2 177-186
- 49 Hernandez-Guerra M, Lopez E, Bellot P et al.. Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome. Hepatology. 2006; 43 27-33
- 50 Bosch J, Arroyo V, Betriu A et al.. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology. 1980; 78 92-99
- 51 Gluud C, Henriksen J H, Nielsen G. Prognostic indicators in alcoholic cirrhotic men. Hepatology. 1988; 8 222-227
- 52 Ripoll C, Banares R, Rincon D et al.. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology. 2005; 42 793-801
- 53 Villanueva C, Lopez-Balaguer J M, Aracil C et al.. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. J Hepatol. 2004; 40 757-765
- 54 D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006; 44 217-231
- 55 Groszmann R J, Garcia-Tsao G, Bosch J et al.. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005; 353 2254-2261
- 56 Merkel C, Bolognesi M, Sacerdoti D et al.. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2000; 32 930-934
- 57 Moller S, Bendtsen F, Christensen E, Henriksen J H. Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding. J Hepatol. 1994; 21 940-946
- 58 Turnes J, Garcia-Pagan J C, Abraldes J G, Hernandez-Guerra M, Dell'Era A, Bosch J. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol. 2006; 101 506-512
- 59 Zimmerer J, Haubitz I, Mainos D, Hadass H, Tittor W. Survival in alcoholic liver cirrhosis: prognostic value of portal pressure, size of esophageal varices and biochemical data. Comparison with Child classification. Z Gastroenterol. 1996; 34 421-427
- 60 Merkel C, Bolognesi M, Bellon S et al.. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology. 1992; 102 973-979
- 61 Tage-Jensen U, Henriksen J H, Christensen E, Widding A, Ring-Larsen H, Christensen N J. Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis. J Hepatol. 1988; 6 350-358
- 62 Bureau C, Peron J M, Alric L et al.. “A la carte” treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology. 2002; 36 1361-1366
- 63 Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou J P. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology. 1980; 79 1139-1144
- 64 Stanley A J, Robinson I, Forrest E H, Jones A L, Hayes P C. Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. QJM. 1998; 91 19-25
- 65 Urbain D, Muls V, Makhoul E, Jeghers O, Thys O, Ham H R. Prognostic significance of hepatic venous pressure gradient in medically treated alcoholic cirrhosis: comparison to aminopyrine breath test. Am J Gastroenterol. 1993; 88 856-859
- 66 Dittrich S, de Mattos A A, Becker M, Goncaves D M, Cheinquer H. Role of hepatic hemodynamic study in the evaluation of patients with cirrhosis. Hepatogastroenterology. 2003; 50 2052-2056
- 67 Vinel J P, Cassigneul J, Levade M, Voigt J J, Pascal J P. Assessment of short-term prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient. Hepatology. 1986; 6 116-117
- 68 Ready J B, Robertson A D, Goff J S, Rector Jr W G. Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure. Gastroenterology. 1991; 100 1403-1410
- 69 Villanueva C, Ortiz J, Minana J et al.. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology. 2001; 121 110-117
- 70 Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L et al.. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004; 40 793-801
- 71 Abraldes J G, Aracil C, Catalina M V et al.. Value of HVPG predicting 5-day treatment failure in acute variceal bleeding: comparison with clinical variables. J Hepatol. 2006; 44(suppl 2) 12A
- 72 Patch D, Armonis A, Sabin C et al.. Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut. 1999; 44 264-269
- 73 Villanueva C, Minana J, Ortiz J et al.. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med. 2001; 345 647-655
- 74 Abraldes J G, Tarantino I, Turnes J, Garcia-Pagan J C, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology. 2003; 37 902-908
- 75 Villanueva C, Balanzo J, Novella M T et al.. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med. 1996; 334 1624-1629
- 76 Patch D, Sabin C A, Goulis J et al.. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology. 2002; 123 1013-1019
- 77 McCormick P A, Patch D, Greenslade L, Chin J, McIntyre N, Burroughs A K. Clinical vs haemodynamic response to drugs in portal hypertension. J Hepatol. 1998; 28 1015-1019
- 78 D'Amico G, Garcia-Pagan J C, Luca A, Bosch J. HVPG reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology. 2006; , In press
- 79 Targownik L E, Spiegel B M, Dulai G S, Karsan H A, Gralnek I M. The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage. Am J Gastroenterol. 2004; 99 1306-1315
- 80 Raines D L, Dupont A W, Arguedas M R. Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding. Aliment Pharmacol Ther. 2004; 19 571-581
- 81 Imperiale T F, Chalasani N, Klein R W. Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis. Am J Gastroenterol. 2003; 98 2742-2750
- 82 Llovet J M, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999; 30 1434-1440
- 83 Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005; 42 1208-1236
- 84 Blasco A, Forns X, Carrion J A et al.. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology. 2006; 43 492-499
- 85 Rincon D, Ripoll C, Iacono O L et al.. Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis. Am J Gastroenterol. 2006; , In press
- 86 de Franchis R. Evolving consensus in portal hypertension: report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005; 43 167-176
- 87 McCormick P A, Nolan N. Palpable epigastric liver as a physical sign of cirrhosis: a prospective study. Eur J Gastroenterol Hepatol. 2004; 16 1331-1334
- 88 de Bruyn G, Graviss E A. A systematic review of the diagnostic accuracy of physical examination for the detection of cirrhosis. BMC Med Inform Decis Mak. 2001; 1 6
- 89 Schepis F, Camma C, Niceforo D et al.. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?. Hepatology. 2001; 33 333-338
- 90 Zaman A, Hapke R, Flora K, Rosen H R, Benner K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol. 1999; 94 3292-3296
- 91 Giannini E, Botta F, Borro P et al.. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003; 52 1200-1205
- 92 Zimbwa T A, Blanshard C, Subramaniam A. Platelet count/spleen diameter ratio as a predictor of oesophageal varices in alcoholic cirrhosis. Gut. 2004; 53 1055
- 93 Braillon A, Cales P, Valla D, Gaudy D, Geoffroy P, Lebrec D. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut. 1986; 27 1204-1209
- 94 Rossi S, Rosa L, Ravetta V et al.. Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR Am J Roentgenol. 2006; 186 763-773
- 95 Sabba C, Merkel C, Zoli M et al.. Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program. Hepatology. 1995; 21 428-433
- 96 Cottone M, D'Amico G, Maringhini A et al.. Predictive value of ultrasonography in the screening of non-ascitic cirrhotic patients with large varices. J Ultrasound Med. 1986; 5 189-192
- 97 Bolondi L, Gandolfi L, Arienti V et al.. Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration. Radiology. 1982; 142 167-172
- 98 Zoli M, Iervese T, Merkel C et al.. Prognostic significance of portal hemodynamics in patients with compensated cirrhosis. J Hepatol. 1993; 17 56-61
- 99 Moriyasu F, Nishida O, Ban N et al.. “Congestion index” of the portal vein. AJR Am J Roentgenol. 1986; 146 735-739
- 100 van Leeuwen M S. Doppler ultrasound in the evaluation of portal hypertension. Clin Diagn Ultrasound. 1990; 26 53-76
- 101 Sacerdoti D, Merkel C, Bolognesi M, Amodio P, Angeli P, Gatta A. Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics. Gastroenterology. 1995; 108 1152-1158
- 102 Iwao T, Toyonaga A, Oho K et al.. Value of Doppler ultrasound parameters of portal vein and hepatic artery in the diagnosis of cirrhosis and portal hypertension [see comments]. Am J Gastroenterol. 1997; 92 1012-1017
- 103 Bolognesi M, Sacerdoti D, Merkel C, Bombonato G, Gatta A. Noninvasive grading of the severity of portal hypertension in cirrhotic patients by echo-color-Doppler. Ultrasound Med Biol. 2001; 27 901-907
- 104 Berzigotti A, Casadei A, Magalotti D et al.. Renovascular impedance correlates with portal pressure in patients with liver cirrhosis. Radiology. 2006; 240 581-586
- 105 Taourel P, Blanc P, Dauzat M et al.. Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure. Hepatology. 1998; 28 932-936
- 106 Schepke M, Raab P, Hoppe A, Schiedermaier P, Brensing K A, Sauerbruch T. Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis. Am J Gastroenterol. 2000; 95 2905-2909
- 107 Iwao T, Oho K, Sakai T et al.. Noninvasive hemodynamic measurements of superior mesenteric artery in the prediction of portal pressure response to propranolol. J Hepatol. 1998; 28 847-855
- 108 Bolognesi M, Sacerdoti D, Merkel C, Bombonato G, Enzo E, Gatta A. Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: comparison between acute and chronic effects. J Hepatol. 1997; 26 305-311
- 109 Zoli M, Marchesini G, Marzocchi A, Marrozzini C, Dondi C, Pisi E. Portal pressure changes induced by medical treatment: US detection. Radiology. 1985; 155 763-766
- 110 Berzigotti A, Rinaldi M F, Magalotti D et al.. Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders. J Hepatol. 2006; 44 310-316
- 111 Materne R, Annet L, Dechambre S et al.. Dynamic computed tomography with low- and high-molecular-mass contrast agents to assess microvascular permeability modifications in a model of liver fibrosis. Clin Sci (Lond). 2002; 103 213-216
- 112 Van Beers B E, Materne R, Annet L et al.. Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrast-enhanced MRI in the rabbit. Magn Reson Med. 2003; 49 692-699
- 113 Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers B E. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology. 2003; 229 409-414
- 114 Foucher J, Chanteloup E, Vergniol J et al.. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006; 55 403-408
- 115 Ziol M, Handra-Luca A, Kettaneh A et al.. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005; 41 48-54
- 116 Carrion J A, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 2006; , Jul 5 (Epub ahead of print)
- 117 Kazemi F, Kettaneh A, N'kontchou G et al.. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol. 2006; 45 230-235
- 118 Bosch J. Predictions from a hard liver. J Hepatol. 2006; 45 174-177
- 119 Feu F, Bordas J M, Luca A et al.. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis. Hepatology. 1993; 18 1082-1089
- 120 Escorsell A, Feu F, Bordas J M et al.. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis. J Hepatol. 1996; 24 423-429
- 121 Feu F, Bordas J M, Garcia-Pagan J C, Bosch J, Rodes J. Double-blind investigation of the effects of propranolol and placebo on the pressure of esophageal varices in patients with portal hypertension. Hepatology. 1991; 13 917-922
- 122 Bosch J, Bordas J M, Rigau J et al.. Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy. Hepatology. 1986; 6 667-672
- 123 Nevens F, Sprengers D, Feu F, Bosch J, Fevery J. Measurement of variceal pressure with an endoscopic pressure sensitive gauge: validation and effect of propranolol therapy in chronic conditions. J Hepatol. 1996; 24 66-73
- 124 Escorsell A, Bosch J.
Pathophysiology of variceal bleeding . In: Groszmann RJ, Bosch J Portal Hypertension in the 21st Century. Dordrecht/Boston/London; Kluwer Academic Publishers 2004: 155-166MissingFormLabel - 125 Ruiz del Arbol L, Martin de Argila C, Vázquez M et al.. Endoscopic measurement of variceal pressure during hemorrhage from esophageal varices. Hepatology. 1992; 16 (suppl 1) 147A
- 126 Nevens F, Bustami R, Scheys I, Lesaffre E, Fevery J. Variceal pressure is a factor predicting the risk of a first variceal bleeding: a prospective cohort study in cirrhotic patients. Hepatology. 1998; 27 15-19
- 127 Bosch J, Bordas J M, Mastai R et al.. Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: comparison with the effects on portal pressure. Hepatology. 1988; 8 861-865
- 128 Caletti G C, Brocchi E, Ferrari A, Fiorino S, Barbara L. Value of endoscopic ultrasonography in the management of portal hypertension. Endoscopy. 1992; 24(suppl 1) 342-346
Prof
Jaime BoschM.D.
Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, C. Villarroel 170
08036 Barcelona, Spain